Astrana Health, Inc. (ASTH)
NASDAQ: ASTH · Real-Time Price · USD
29.06
+0.38 (1.32%)
Nov 20, 2026, 3:25 PM EST - Market open
Astrana Health Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 30.39 | 30.39 | 13.98 | 38.68 | 41.09 | 35.96 |
Other Revenue | 3,881 | 3,151 | 2,021 | 1,348 | 1,103 | 737.96 |
| 3,912 | 3,182 | 2,035 | 1,387 | 1,144 | 773.92 | |
Revenue Growth | 35.05% | 56.39% | 46.72% | 21.19% | 47.84% | 12.62% |
Cost of Revenue | 3,483 | 2,840 | 1,763 | 1,172 | 944.69 | 596.14 |
Gross Profit | 428.36 | 341.53 | 271.39 | 214.96 | 199.48 | 177.77 |
Selling, General & Admin | 262.95 | 197.66 | 154.11 | 112.6 | 77.67 | 62.08 |
Operating Expenses | 326 | 243.41 | 182.04 | 130.35 | 95.21 | 79.59 |
Operating Income | 102.36 | 98.13 | 89.35 | 84.61 | 104.27 | 98.18 |
Interest Expense | -69.64 | -54.93 | -33.1 | -16.1 | -7.92 | -5.39 |
Interest & Investment Income | 17.86 | 12.16 | 14.51 | 14.21 | 1.98 | 1.57 |
Earnings From Equity Investments | 4.3 | 1.71 | 4.45 | 5.58 | 5.62 | -4.31 |
Other Non Operating Income (Expenses) | 1.69 | -1.39 | 4.88 | 6.12 | 2.57 | 3.92 |
EBT Excluding Unusual Items | 56.57 | 55.67 | 80.09 | 94.42 | 106.52 | 93.97 |
Merger & Restructuring Charges | 10.2 | -19.6 | - | - | - | - |
Gain (Loss) on Sale of Investments | 7.71 | -0.07 | 0.73 | -4.58 | -19 | -18.98 |
Other Unusual Items | 12.17 | 3.6 | - | - | -0.9 | 2.75 |
Pretax Income | 86.65 | 39.61 | 80.82 | 89.84 | 86.62 | 77.75 |
Income Tax Expense | 28.23 | 15.53 | 30.89 | 31.99 | 40.88 | 31.69 |
Earnings From Continuing Operations | 58.41 | 24.08 | 49.93 | 57.85 | 45.74 | 46.06 |
Minority Interest in Earnings | -5.29 | -1.59 | -6.78 | 2.87 | -0.57 | 22.87 |
Net Income | 53.13 | 22.49 | 43.15 | 60.72 | 45.17 | 68.92 |
Net Income to Common | 53.13 | 22.49 | 43.15 | 60.72 | 45.17 | 68.92 |
Net Income Growth | 457.05% | -47.88% | -28.93% | 34.42% | -34.46% | 82.88% |
Shares Outstanding (Basic) | 49 | 49 | 48 | 47 | 45 | 44 |
Shares Outstanding (Diluted) | 50 | 49 | 48 | 47 | 46 | 45 |
Shares Change | 1.20% | 2.91% | 2.20% | 2.94% | 0.44% | 21.24% |
EPS (Basic) | 1.08 | 0.46 | 0.91 | 1.30 | 1.00 | 1.57 |
EPS (Diluted) | 1.08 | 0.46 | 0.90 | 1.29 | 0.99 | 1.52 |
EPS Growth | 452.83% | -49.09% | -30.23% | 30.30% | -34.87% | 50.50% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 99.42 | 104.49 | 44.17 | 39.7 | 59.19 | 51.11 |
Free Cash Flow Per Share | 2.00 | 2.12 | 0.92 | 0.85 | 1.30 | 1.13 |
Gross Margin | 10.95% | 10.73% | 13.34% | 15.50% | 17.43% | 22.97% |
Operating Margin | 2.62% | 3.08% | 4.39% | 6.10% | 9.11% | 12.69% |
Profit Margin | 1.36% | 0.71% | 2.12% | 4.38% | 3.95% | 8.91% |
Free Cash Flow Margin | 2.54% | 3.28% | 2.17% | 2.86% | 5.17% | 6.60% |
EBITDA | 165.41 | 143.87 | 117.28 | 102.36 | 121.81 | 115.7 |
EBITDA Margin | 4.23% | 4.52% | 5.76% | 7.38% | 10.65% | 14.95% |
D&A For EBITDA | 63.05 | 45.75 | 27.93 | 17.75 | 17.54 | 17.52 |
EBIT | 102.36 | 98.13 | 89.35 | 84.61 | 104.27 | 98.18 |
EBIT Margin | 2.62% | 3.08% | 4.39% | 6.10% | 9.11% | 12.69% |
Effective Tax Rate | 32.58% | 39.21% | 38.22% | 35.61% | 47.19% | 40.76% |
Revenue as Reported | 3,182 | 3,182 | 2,035 | 1,387 | 1,144 | 773.92 |